Cardiol Therapeutics Inc. CRDL
1.05 USD -0.07 -5.86%
As of Nov 2, 1:37 PM ET
- Open
- 1.11
- Prev close
- 1.11
- Mkt cap
- 126.98M
- Vol
- 545.93K
- Avg vol
- 1.38M
- EPS
- -0.25
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.04
- High
- 1.12
- Forward P/E
- -4.03
- Beta
- 0.70
- Short ratio
- 1.37
- Inst. own
- 9.51%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 12, 2024
- 50-d avg
- 1.70
- 200-d avg
- 1.95
- 1y target
- 8.70
MAX chart
Chart tools
Chart is warming up
The all-time price history for CRDL has not been loaded yet. Try again in a moment.
Altman Z-Score
6.94 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
P/E -3.4×
P/S 0.0×
P/B 6.4×
P/FCF -4.8×
EV/EBITDA -2.7×
EV/Sales 0.0×
FCF Yield -21.0%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -189.2%
ROIC -190.6%
ROA -143.2%
Revenue 0.0%
Operating Income 14.8%
EPS (diluted) 23.5%
Free Cash Flow 4.8%
Current Ratio 4.2×
Quick Ratio 4.2×
Debt / Equity 0.0×
Net Debt / EBITDA 0.6×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31